Company / R&D Expense
Rallybio Corp R&D Expense History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$41.5M
FY2025
5-year range
$41.5M / $53.5M
FY2024-FY2025
Trend
-22.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$42M in FY2025.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d expense decreased 22.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score 40.31 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $41.5M | -22.5% |
| FY2024 | $53.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026